Karima Begriche

Rennes, 35000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

The history of β-aminoisobutyric acid: from a waste metabolite to a druggable compound for metabolic disease. A narrative review.

The history of β-aminoisobutyric acid: from a waste metabolite to a druggable compound for metabolic disease. A narrative review.

Journal: European journal of pharmacology

Published: November 18, 2025

Use of stable isotope-labeled fatty acids to measure desaturase activities with negative chemical ionization GC-MS.

Use of stable isotope-labeled fatty acids to measure desaturase activities with negative chemical ionization GC-MS.

Journal: Chemistry and physics of lipids

Published: September 29, 2024

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review.

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review.

Journal: Livers

Published: January 30, 2023

Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease.

Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease.

Journal: International journal of molecular sciences

Published: December 14, 2021

Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver.

Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver.

Journal: Cells

Published: December 09, 2021

Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis.

Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis.

Journal: Clinics and research in hepatology and gastroenterology

Published: May 13, 2020

Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity.

Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity.

Journal: Cell biology and toxicology

Published: March 20, 2020

Drug-induced liver injury in obesity and nonalcoholic fatty liver disease.

Drug-induced liver injury in obesity and nonalcoholic fatty liver disease.

Journal: Advances in pharmacology (San Diego, Calif.)

Published: July 17, 2019

Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids.

Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids.

Journal: European journal of nutrition

Published: January 25, 2019

Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure.

Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure.

Journal: Oxidative medicine and cellular longevity

Published: April 06, 2018

Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells.

Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells.

Journal: The Journal of pharmacology and experimental therapeutics

Published: November 29, 2017

Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.

Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.

Journal: Journal of clinical and translational research

Published: July 11, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026